Zobrazeno 1 - 10
of 47
pro vyhledávání: '"I, Fornís"'
Autor:
D. Fabregat-Safont, X. Carbón, M. Ventura, I. Fornís, E. Guillamón, J. V. Sancho, F. Hernández, M. Ibáñez
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-14 (2017)
Abstract New psychoactive substances have been rapidly growing in popularity in the drug market as non-illegal drugs. In the last few years, an increment has been reported on the use of synthetic alternatives to heroin, the synthetic opioids. Based o
Externí odkaz:
https://doaj.org/article/c75b26e87cc84f5294108f5f400617ff
Autor:
I. Fornís, David Fabregat-Safont, Cristina Gil, Mireia Ventura, N. Calzada, María Ibáñez, Félix Hernández, Juan V. Sancho
Publikováno v:
Drug Testing and Analysis. 9:1073-1080
Publikováno v:
Repositori Universitat Jaume I
Universitat Jaume I
Scientific Reports, Vol 9, Iss 1, Pp 1-8 (2019)
Scientific Reports
Universitat Jaume I
Scientific Reports, Vol 9, Iss 1, Pp 1-8 (2019)
Scientific Reports
Despite the fact that 33% of the new psychoactive substances seized in 2015 were synthetic cathinones, the number of these derivatives has been decreasing in the last years, probably as a consequence of the unfavourable effects reported by users. Thu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4ac161cb34ad623232ea9498c90119e
http://hdl.handle.net/10234/183130
http://hdl.handle.net/10234/183130
Autor:
Mireia Ventura, I. Fornís, M. Grifell, Francina Fonseca, Magí Farré, Liliana Galindo, Álvaro José Palma-Conesa, P. Quintana, Marta Torrens, Cristina Gil
Publikováno v:
Journal of Psychoactive Drugs
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
New psychoactive tryptamines may be a public health risk since they intend to mimic the hallucinogenic effects of regulated psychoactive drugs. Few studies describe uses and clinical effects of unregulated new psychoactive tryptamines. This study aim
Publikováno v:
Human Psychopharmacology: Clinical and Experimental. 28:341-344
Objective The aim of this study was to describe the presence and composition of cathinone derivatives (CDs) in drug samples analyzed at a Drug Testing Service. Material and methods Data provided by the Drug Testing Service at Energy Control (a Spanis
Autor:
D, Fabregat-Safont, I, Fornís, M, Ventura, C, Gil, N, Calzada, J V, Sancho, F, Hernández, M, Ibáñez
Publikováno v:
Drug testing and analysis. 9(7)
Autor:
M. Grifell, Magí Farré, Mireia Ventura, Fernando Caudevilla, I. Fornís, Liliana Galindo, Xoán Carbón, Marta Torrens, Cristina Gil, Alvaro T. Palma, P. Quintana
Publikováno v:
International Journal of Drug Policy
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Background: The popularization of anonymous markets such as Silk Road is challenging current drug policy and may provide a new context for old issues, such as adulteration of heroin with fentanyl derivatives. The aims of this paper are to report the
Autor:
Claudio Vidal, Ana Muñoz, Mireia Ventura, Cristina Gil Lladanosa, Monica J. Barratt, P. Quintana, I. Fornís, Nuria Calzada, Fernando Caudevilla
Publikováno v:
The International journal on drug policy. 35
Introduction User surveys indicate that expectations of higher drug purity are a key reason for cryptomarket use. In 2014–2015, Spain's NGO Energy Control conducted a 1-year pilot project to provide a testing service to cryptomarket drug users usin
Autor:
M.F. Fonseca, I. Fornís, Mireia Ventura, M. Grifell, A. Palma Conesa, P. Quintana, Marta Torrens, Cristina Gil, Liliana Galindo, Magí Farré
Publikováno v:
European Neuropsychopharmacology. 26:S706-S707
Autor:
Á. Palma, I. Fornís, Marta Torrens, Mireia Ventura, J. Tirado, P. Quintana, Magí Farré, M. Grifell, Liliana Galindo
Publikováno v:
European Psychiatry. 33:S115-S116
IntroductionSince 2004, herbal mixtures for smoking use have been sold under the generic brand “Spice”. Many of them contain synthetic cannabinoids (agonists of the cannabinoid receptors). JWH-018 was one of the first spice drugs. There is no sci